SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-088114
Filing Date
2016-11-29
Accepted
2016-11-29 20:06:28
Documents
2
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1649
2 EXHIBIT LIST - EXHIBIT 24.1 - POWER OF ATTORNEY poa_resnick.htm EX-24.1 5799
  Complete submission text file 0001140361-16-088114.txt   9174
Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ
Business Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN SALISBURY, WILTSHIRE X0 SP4 0JQ 44 0 1980 753002
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108
Business Address
Resnick Joshua (Reporting) CIK: 0001690959 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 162023839